Meridian Bioscience (VIVO) Declares $0.125 Quarterly Dividend; 3.5% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Meridian Bioscience Reports Second Quarter 2017 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance
April 27, 2017 7:45 AM EDTGENERAL HIGHLIGHTS
CINCINNATI, April 27, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today:
reported fiscal 2017 second quarter and first six months net revenues of $54.1 and $100.9 million, respectively, increases of 6% and 3%, respectively, from the same period of the prior fiscal year; reported second quarter operating income of $14.2 million, a decrease of 6% from the same period of the prior fiscal year; reported six months operating income of $24.3 million, a decrease of 16% from the same period of the prior fiscal year;... More


